Association between patient activity and long-term cardiac death in patients with implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators

Abstract

Background

Patient activity (PA) has been demonstrated to predict all-cause mortality. However, the association between PA and cardiac death is unclear.

Aims

The aims of this study were to determine whether PA can predict cardiac death and what is the cut-off of PA to discriminate cardiac death, as well as the mechanism underlying the relationship between PA and survival in patients with home monitoring.

Methods

This study retrospectively analysed clinical and implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillator device data in 845 patients. Data regarding PA and PP variability during the first 30–60 days of home monitoring were collected, and mean values were calculated. The primary endpoint was cardiac death, and the secondary endpoint was all-cause mortality.

Results

The mean PA percentage was 11 ± 5.8%. Based on receiver operating characteristic curve analysis, we determined that a PA cut-off value of 7.84% (113 min) can predict cardiac death. During a mean follow-up period of 31.1 ± 12.9 months (ranging from three to 60 months), PA ≤ 7.84% was associated with increased risks of cardiac death in an unadjusted analysis; after adjusting in a multivariate Cox model, the relationship remained significant between PA≤7.84% and cardiac death (hazard ratio = 3.644, 95% confidence interval = 2.424–5.477, p < 0.001). Moreover, a significant correlation was observed between PA and PP variability (r = 0.601, p < 0.001).

Conclusions

A baseline PA ≤ 7.84% was associated with a higher risk of cardiac death in patients who have survived more than three months after implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillator implantation. PA had a sizable effect on heart rate variability, reflecting autonomic function.

Keywords

Patient activity heart rate variability cardiac death implantable cardioverter-defibrillator cardiac resynchronization therapy defibrillator

Get full access to this article

View all access options for this article.

References

Myers

Prakash

Froelicher

. Exercise capacity and mortality among men referred for exercise testing. New Engl J Med 2002; 346: 793–801.

Thakkar

Redfern

Thiagalingam

. Patterns, predictors and effects of texting intervention on physical activity in CHD – insights from the TEXT ME randomized clinical trial. Eur J Prev Cardiol 2016; 23: 1894–1902.

Johansen

Kaysen

Dalrymple

. Association of physical activity with survival among ambulatory patients on dialysis: The Comprehensive Dialysis Study. Clin J Am Soc Nephrol 2013; 8: 248–253.

Waschki

Kirsten

Holz

. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: A prospective cohort study. Chest 2011; 140: 331–342.

Skielboe

Marott

Dixen

. Occupational physical activity, but not leisure-time physical activity increases the risk of atrial fibrillation: The Copenhagen City Heart Study. Eur J Prev Cardiol 2016; 23: 1883–1893.

Conraads

Spruit

Braunschweig

. Physical activity measured with implanted devices predicts patient outcome in chronic heart failure. Circ Heart Fail 2014; 7: 279–287.

Whellan

Ousdigian

Al-Khatib

. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: Results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J Am Coll Cardiol 2010; 55: 1803–1810.

Pop-Busui

Evans

Gerstein

. Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care 2010; 33: 1578–1584.

Kurths

Voss

Saparin

. Quantitative analysis of heart rate variability. Chaos 1995; 5: 88–94.

10.

La Rovere

Bigger

Jr Marcus

. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998; 351: 478–484.

11.

Kramer

Mitchell

Monteiro

. Patient activity and survival following implantable cardioverter-defibrillator implantation: The ALTITUDE activity study. J Am Heart Assoc 2015; 4: e001775.

12.

Gula

Wells

Yee

. A novel algorithm to assess risk of heart failure exacerbation using ICD diagnostics: Validation from RAFT. Heart Rhythm 2014; 11: 1626–1631.

13.

Vegh

Kandala

Orencole

. Device-measured physical activity versus six-minute walk test as a predictor of reverse remodeling and outcome after cardiac resynchronization therapy for heart failure. Am J Cardiol 2014; 113: 1523–1528.

14.

Allesoe

Holtermann

Aadahl

. High occupational physical activity and risk of ischaemic heart disease in women: The interplay with physical activity during leisure time. Eur J Prev Cardiol 2015; 22: 1601–1608.

15.

Furlan

Piazza

Dell'Orto

. Early and late effects of exercise and athletic training on neural mechanisms controlling heart rate. Cardiovasc Res 1993; 27: 482–488.

16.

Bernardi

Valle

Coco

. Physical activity influences heart rate variability and very-low-frequency components in Holter electrocardiograms. Cardiovasc Res 1996; 32: 234–237.

17.

Osterhues

Hanzel

Kochs

. Influence of physical activity on 24-hour measurements of heart rate variability in patients with coronary artery disease. Am J Cardiol 1997; 80: 1434–1437.

18.

Thuraisingham

. Preprocessing RR interval time series for heart rate variability analysis and estimates of standard deviation of RR intervals. Comput Methods Programs Biomed 2006; 83: 78–82.